Market Research Logo

Conference Documentation: Asthma & COPD

Conference Documentation: Asthma & COPD

Asthma and COPD together create an enormous public health burden and an urgent need for progress in disease understanding, therapy and care. Join us at SMi's 11th annual Asthma & COPD conference to share in the experiences of leading lights in the field who are addressing the challenges of solving the riddle of pathogenesis, biomarkers and endpoints, personalising therapies vs. the unmet need, tackling the causes and consequences of exacerbations, development of new animal models and better tools for disease diagnosis and monitoring.

This conference will give delegates invaluable insights into the key thinking and advances in the respiratory drug market, focusing on the challenges and solutions to enhance patient outcomes, providing extensive knowledge from the key leading industry, academic and care providing experts.


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London
9:10
Children’s asthma treatments are like children’s clothes: make sure they fit
Andrew Bush, Professor of Paediatric Respirology, Imperial College London and Royal Brompton Hospital
9:40
Unravelling mechanisms of asthma exacerbations and implications for the future
Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London
10:10
Morning Coffee
10:40
Is neutrophilic/non-eosinophilic inflammation an appropriate therapeutic target in asthma?
Neil C Thomson, Professor of Respiratory Medicine, University of Glasgow
11:10
Mechanisms mediating paediatric severe asthma: translational approaches
Sejal Saglani, Reader in Respiratory Paediatrics , Imperial College London
11:40
Cytokine regulation of pulmonary inflammation and remodelling in asthma
Clare Lloyd, Professor of Respiratory Immunology, Imperial College London
12:10
Networking Lunch
13:10
Changing role of patient charities in research – what can we offer?
Samantha Walker, Executive Director, Research & Policy, Asthma UK
13:40
Enabling targeted therapy for severe asthma through molecular phenotyping and biomarker development
Joseph Arron, Associate Director, Biomarker Discovery, Genentech, Inc.
14:10
New therapeutic approaches for asthma: It’s all about the airways
Dirk Smith, Scientific Director , Amgen
14:40
Eosinophilic inflammation and exacerbations of asthma and COPD: A fatal liaison
Roland Kolbeck, Respiratory, Inflammation & Autoimmunity, MedImmune
15:10
Afternoon Tea
15:40
Asthma and COPD phenotypes – how reliable are they?
Mona Bafadhel, Senior Lecturer Respiratory Medicine & NIHR Post-Doctoral Fellow, University Of Oxford
16:10
The ADEPT study: airways disease endotyping for personalised therapeutics in asthma and COPD
Philip E Silkoff, Senior Director, Immunology, Pulmonary Disease Area, Janssen Inc
16:40
Chairman’s Closing Remarks and Close of Day One
Sebastian Johnston, Professor of Respiratory Medicine, National Heart and Lung Institute, Imperial College London
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Robert Niven, Senior Lecturer in Respiratory Medicine, University of Manchester
9:10
Ceramide 1-phosphate (C1P), a potential new therapeutic target for COPD
Antonio Gomez-Munoz, Professor of Biochemistry and Molecular Biology, University of the Basque Country
9:50
Viruses in asthma and COPD
Patrick Mallia, Senior Clinical Lecturer, Imperial College London
10:20
Drug development challenges associated with inhaled and intranasal antivirals
Staffan Edsbacker, Global Project Director and Associate Professor , AstraZeneca R&D Mölndal and University of Lund
10:50
Morning Coffee
11:20
Round Table Discussion: Challenges and choices in stratified asthma therapeutics
Robert Niven, Senior Lecturer in Respiratory Medicine, University of Manchester
11:50
Always on, always with you. The role of personal technology and the digital economy in respiratory health
John Blakey, Senior Clinical Lecturer, Liverpool School of Tropical Medicine
11:50
Always on, always with you. The role of personal technology and the digital economy in respiratory health
James Pinchin, Research Fellow, Horizon DERC, The University of Nottingham
12:30
Networking Lunch
13:30
RPL554 as a novel treatment for severe COPD
Jan-Anders Karlsson, CEO , Verona Pharma
14:00
New role of theophylline in COPD
Kirsten Kaiser, Executive Vice President Medical & Regulatory Development, SkyePharma AG
14:30
Afternoon Tea
15:00
Pulmonary rehabilitation in the real world
Maria Buxton, Consultant Respiratory Physiotherapist , London North West Healthcare NHS Trust
15:30
COPD: Unmet need and challenges in NHS Care
John Hurst, Consultant in Respiratory Medicine, University College London
16:00
Chairman’s Closing Remarks and Close of Day Two

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report